Infectious clones of novel lineage 1 and lineage 2 West Nile Virus strains WNV-TX02 and WNV-Madagascar

Journal of Virology

Volumn 86, Issue 14, 2012, Pages 7704-7709

  Suthar, Mehul S ^a   Brassil, Margaret M ^a   Blahnik, Gabriele ^a   Gale, Michael ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; STAT1 PROTEIN; STAT2 PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA REPLICATION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENESCENCE; VIRUS STRAIN; VIRUS VIRULENCE; WEST NILE FLAVIVIRUS;

FLAVIVIRUS; WEST NILE VIRUS;

EID: 84863762462     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00401-12     Document Type: Article

References (21)

1. Andzhaparidze OG, Bogomolova NN, Boriskin YS, Bektemirova MS, Drynov ID. 1981. Comparative study of rabies virus persistence in human and hamster cell lines. J. Virol. 37:1- 6.
2. Beasley DW, Li L, Suderman MT, Barrett AD. 2002. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296:17-23.
3. Berthet FX, et al. 1997. Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J. Gen. Virol. 78(Pt 9):2293-2297.
4. Centers for Disease Control and Prevention. 2011. West Nile virus disease and other arboviral diseases-United States, 2010.MMWRMorb. Mortal. Wkly. Rep. 60:1009-1013.
5. Clarke JB, Spier RE. 1983. An investigation into causes of resistance of a cloned line of BHK cells to a strain of foot-and-mouth disease virus. Vet. Microbiol. 8:259-270.
6. DeBiasi RL, Parsons JA, Grabert BE. 2005. West Nile virus meningoencephalitis in an immunocompetent adolescent. Pediatr. Neurol. 33:217- 219.
7. Emig M, Apple DJ. 2004. Severe West Nile virus disease in healthy adults. Clin. Infect. Dis. 38:289-292.
8. Evans JD, Seeger C. 2007. Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J. Virol. 81:11809-11816.
9. Keller BC, et al. 2006. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J. Virol. 80:9424- 9434.
10. Kinney RM, et al. 2006. Avian virulence and thermostable replication of the North American strain of West Nile virus. J. Gen. Virol. 87:3611-3622.
11. Laassri M, Bidzhieva B, Speicher J, Pletnev AG, Chumakov K. 2011. Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virus. J. Med. Virol. 83:910-920.
12. Lanciotti RS, et al. 2002. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298:96-105.
13. Laurent-Rolle M, et al. 2010. The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J. Virol. 84:3503-3515.
14. Liu WJ, et al. 2006. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J. Virol. 80:2396- 2404.
15. Liu WJ, et al. 2005. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J. Virol. 79:1934-1942.
16. Muñoz-Jordán JL, et al. 2005. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79:8004-8013.
17. Papa A, Xanthopoulou K, Gewehr S, Mourelatos S. 2011. Detection of West Nile virus lineage 2 in mosquitoes during a human outbreak in Greece. Clin. Microbiol. Infect. 17:1176-1180.
18. Perwitasari O, Cho H, Diamond MS, Gale M, Jr. 2011. Inhibitor of kappaB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection. J. Biol. Chem. 286:44412- 44423.
19. Samuel MA, Diamond MS. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79:13350-13361.
20. Schuessler A, et al. 2012. West Nile virus noncoding subgenomic RNA contributes to viral evasion of type I interferon-mediated antiviral response. J. Virol. 86:5708-5718.
21. Suthar MS, et al. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6:e1000757. doi:10.1371/ journal.ppat.1000757.